The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Holostem Terapie Avanzate S.r.l.EU/1/14/987/001

Main Information

Trade NameHoloclar
Active SubstancesEx vivo expanded autologous corneal epithelial cells containing stem cells
Dosage FormLiving tissue equivalent
Licence HolderHolostem Terapie Avanzate S.r.l.
Licence NumberEU/1/14/987/001

Group Information

ATC CodeS01XA19 limbal stems cells, autologous


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back